Rigel says arthritis drug shows progress; shares soar - Reuters

The Money Times

Rigel says arthritis drug shows progress; shares soar Reuters O) said results from a mid-stage study of its lead drug candidate showed significant improvement in patients suffering from rheumatoid arthritis, ... Rigel says rheumatoid arthritis drug met goalCNBC all 55 news articles »

Study Clears Gene Therapy in Death of Arthritis Patient - MedPage Today

Study Clears Gene Therapy in Death of Arthritis Patient MedPage Today The patient, a 35-year-old woman with a 15-year history of rheumatoid arthritis, first presented three days after receiving a second injection on July 2, ... and more »

Array Reports Top-Line Results In Two Phase-I Clinical Trials - Pharmaceutical Business Review

Array Reports Top-Line Results In Two Phase-I Clinical Trials Pharmaceutical Business Review The top-line results were announced in a second study, where ARRY-797 was evaluated in a 28-day phase 1b trial in stable rheumatoid arthritis (RA) patients ... Array BioPharma Announces Top-Line Results in Two Phase 1 Clinical ...Genetic Engineering News (press release) PennyPerformers.com: "Penny Stocks that Perform" picks are: ARRY ...Trading Markets (press release) all 20 news articles »

Drug cartels control the World Health Org. toxic vaccines - Cleveland Indy Media

Drug cartels control the World Health Org. toxic vaccines Cleveland Indy Media There's a "close match between the squalene-induced diseases in animals and those observed in humans injected with this oil: rheumatoid arthritis, ... and more »